| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 1.41e-05 | 6 | 180 | 3 | GO:0008349 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.28e-05 | 6 | 180 | 3 | GO:0051552 | |
| GeneOntologyBiologicalProcess | positive regulation of chondrocyte differentiation | 5.20e-05 | 24 | 180 | 4 | GO:0032332 | |
| GeneOntologyBiologicalProcess | cellular response to phenylpropanoid | 7.57e-05 | 2 | 180 | 2 | GO:1905546 | |
| GeneOntologyBiologicalProcess | cellular response to hydroxyisoflavone | 7.57e-05 | 2 | 180 | 2 | GO:0071413 | |
| GeneOntologyBiologicalProcess | cellular response to genistein | 7.57e-05 | 2 | 180 | 2 | GO:0071412 | |
| Domain | DUF3398 | 1.21e-07 | 6 | 179 | 4 | PF11878 | |
| Domain | DOCK_C/D_N | 1.21e-07 | 6 | 179 | 4 | IPR021816 | |
| Domain | DUF3523 | 8.66e-07 | 3 | 179 | 3 | IPR021911 | |
| Domain | DUF3523 | 8.66e-07 | 3 | 179 | 3 | PF12037 | |
| Domain | DHR-1_domain | 2.55e-06 | 11 | 179 | 4 | IPR027007 | |
| Domain | DHR_2 | 2.55e-06 | 11 | 179 | 4 | PS51651 | |
| Domain | DHR_1 | 2.55e-06 | 11 | 179 | 4 | PS51650 | |
| Domain | DHR-2 | 2.55e-06 | 11 | 179 | 4 | PF06920 | |
| Domain | DOCK | 2.55e-06 | 11 | 179 | 4 | IPR026791 | |
| Domain | DOCK_C | 2.55e-06 | 11 | 179 | 4 | IPR010703 | |
| Domain | DOCK-C2 | 2.55e-06 | 11 | 179 | 4 | PF14429 | |
| Domain | DHR-2 | 2.55e-06 | 11 | 179 | 4 | IPR027357 | |
| Domain | TF_Brachyury | 1.70e-05 | 6 | 179 | 3 | IPR002070 | |
| Domain | UDPGT | 4.30e-05 | 21 | 179 | 4 | PF00201 | |
| Domain | UDPGT | 4.30e-05 | 21 | 179 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 4.30e-05 | 21 | 179 | 4 | IPR002213 | |
| Domain | Amidase_CS | 9.13e-05 | 2 | 179 | 2 | IPR020556 | |
| Domain | NSL3/Tex30 | 9.13e-05 | 2 | 179 | 2 | IPR026555 | |
| Domain | Amidase | 2.72e-04 | 3 | 179 | 2 | IPR000120 | |
| Domain | - | 2.72e-04 | 3 | 179 | 2 | 3.90.1300.10 | |
| Domain | AMIDASES | 2.72e-04 | 3 | 179 | 2 | PS00571 | |
| Domain | Amidase_dom | 2.72e-04 | 3 | 179 | 2 | IPR023631 | |
| Domain | Amidase | 2.72e-04 | 3 | 179 | 2 | PF01425 | |
| Domain | CNH | 2.92e-04 | 14 | 179 | 3 | SM00036 | |
| Domain | WD_REPEATS_1 | 3.60e-04 | 278 | 179 | 10 | PS00678 | |
| Domain | CNH | 3.62e-04 | 15 | 179 | 3 | PF00780 | |
| Domain | CNH | 3.62e-04 | 15 | 179 | 3 | PS50219 | |
| Domain | CNH_dom | 3.62e-04 | 15 | 179 | 3 | IPR001180 | |
| Domain | WD_REPEATS_2 | 3.71e-04 | 279 | 179 | 10 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.71e-04 | 279 | 179 | 10 | PS50294 | |
| Domain | TF_T-box | 5.33e-04 | 17 | 179 | 3 | IPR001699 | |
| Domain | TBOX | 5.33e-04 | 17 | 179 | 3 | SM00425 | |
| Domain | TF_T-box_CS | 5.33e-04 | 17 | 179 | 3 | IPR018186 | |
| Domain | - | 5.33e-04 | 17 | 179 | 3 | 2.60.40.820 | |
| Domain | TBOX_3 | 5.33e-04 | 17 | 179 | 3 | PS50252 | |
| Domain | T-box | 5.33e-04 | 17 | 179 | 3 | PF00907 | |
| Domain | TBOX_1 | 5.33e-04 | 17 | 179 | 3 | PS01283 | |
| Domain | TBOX_2 | 5.33e-04 | 17 | 179 | 3 | PS01264 | |
| Domain | MAPKKKK | 5.41e-04 | 4 | 179 | 2 | IPR021160 | |
| Domain | Nxph | 5.41e-04 | 4 | 179 | 2 | IPR010450 | |
| Domain | WD40 | 1.15e-03 | 268 | 179 | 9 | SM00320 | |
| Domain | WD40_repeat | 1.27e-03 | 272 | 179 | 9 | IPR001680 | |
| Domain | Spectrin | 1.33e-03 | 23 | 179 | 3 | PF00435 | |
| Domain | - | 1.44e-03 | 333 | 179 | 10 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.50e-03 | 335 | 179 | 10 | IPR015943 | |
| Domain | p53-like_TF_DNA-bd | 1.66e-03 | 53 | 179 | 4 | IPR008967 | |
| Domain | HMG_box | 1.66e-03 | 53 | 179 | 4 | PF00505 | |
| Domain | HMG_BOX_2 | 1.78e-03 | 54 | 179 | 4 | PS50118 | |
| Domain | HMG | 1.78e-03 | 54 | 179 | 4 | SM00398 | |
| Domain | ATPase_AAA_core | 1.78e-03 | 54 | 179 | 4 | IPR003959 | |
| Domain | Carn_acyl_trans | 1.86e-03 | 7 | 179 | 2 | IPR000542 | |
| Domain | Carn_acyltransf | 1.86e-03 | 7 | 179 | 2 | PF00755 | |
| Domain | ACYLTRANSF_C_1 | 1.86e-03 | 7 | 179 | 2 | PS00439 | |
| Domain | Myosin_TH1 | 1.86e-03 | 7 | 179 | 2 | PF06017 | |
| Domain | ACYLTRANSF_C_2 | 1.86e-03 | 7 | 179 | 2 | PS00440 | |
| Domain | Myosin_TH1 | 1.86e-03 | 7 | 179 | 2 | IPR010926 | |
| Domain | TH1 | 1.86e-03 | 7 | 179 | 2 | PS51757 | |
| Domain | WD40_repeat_dom | 2.32e-03 | 297 | 179 | 9 | IPR017986 | |
| Domain | Neurexophilin | 2.46e-03 | 8 | 179 | 2 | PF06312 | |
| Domain | NXPH/NXPE | 2.46e-03 | 8 | 179 | 2 | IPR026845 | |
| Domain | Spectrin_repeat | 2.63e-03 | 29 | 179 | 3 | IPR002017 | |
| Domain | AAA | 2.67e-03 | 144 | 179 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 2.67e-03 | 144 | 179 | 6 | IPR003593 | |
| Pathway | PID_TNF_PATHWAY | 3.63e-06 | 46 | 129 | 6 | M128 | |
| Pathway | REACTOME_GLUCURONIDATION | 6.17e-05 | 24 | 129 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 7.29e-05 | 25 | 129 | 4 | M17787 | |
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 28549128 | ||
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 38923254 | ||
| Pubmed | ATAD3A has a scaffolding role regulating mitochondria inner membrane structure and protein assembly. | 1.48e-07 | 3 | 185 | 3 | 34936866 | |
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 25375035 | ||
| Pubmed | Roles of the DOCK-D family proteins in a mouse model of neuroinflammation. | 1.48e-07 | 3 | 185 | 3 | 32241915 | |
| Pubmed | [ATAD3, a vital membrane-bound mitochondrial ATPase involved in tumor progression]. | 1.48e-07 | 3 | 185 | 3 | 22192748 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 MYO1E UBE4B PUF60 DOCK9 CFAP43 JADE1 RALGAPA2 WNK1 EML3 MADD HIRA KANSL3 ZNF335 INTS11 NFX1 MFN2 DEPDC5 MCF2L PC ENDOG | 5.11e-07 | 1105 | 185 | 21 | 35748872 |
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 36736924 | ||
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 38250153 | ||
| Pubmed | ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheimer's disease models. | 5.90e-07 | 4 | 185 | 3 | 35236834 | |
| Pubmed | 5.90e-07 | 4 | 185 | 3 | 29242539 | ||
| Pubmed | 7.44e-07 | 14 | 185 | 4 | 12432077 | ||
| Pubmed | UBR1 NDUFAF5 YTHDC2 ATAD3B TMEM242 CLPB ATAD3A NUP37 INTS11 DOCK7 TMEM209 HSD17B4 EIF4G3 ENDOG | 7.75e-07 | 515 | 185 | 14 | 31617661 | |
| Pubmed | 1.47e-06 | 5 | 185 | 3 | 29898916 | ||
| Pubmed | 1.47e-06 | 5 | 185 | 3 | 20940257 | ||
| Pubmed | Expression analysis of ATAD3 isoforms in rodent and human cell lines and tissues. | 1.47e-06 | 5 | 185 | 3 | 24239551 | |
| Pubmed | 1.47e-06 | 5 | 185 | 3 | 15710388 | ||
| Pubmed | MON2 UBE4B DOCK9 DOCK10 MADD SEL1L3 DOCK7 MFN2 MACF1 MCF2L TMEM181 WDR48 | 2.12e-06 | 407 | 185 | 12 | 12693553 | |
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | SPTBN1 YTHDC2 IDH1 WNK1 KBTBD7 ZNF512B TMTC1 SOWAHA DEPDC5 TMEM181 | 2.21e-06 | 272 | 185 | 10 | 18187620 |
| Pubmed | The RhoGEF DOCK10 is essential for dendritic spine morphogenesis. | 2.93e-06 | 6 | 185 | 3 | 25851601 | |
| Pubmed | 2.93e-06 | 6 | 185 | 3 | 31472450 | ||
| Pubmed | MON2 ASRGL1 DOCK9 SPTBN1 NXPH1 TMEM43 ATE1 GABBR2 WDR26 MADD STT3B ATAD3B ATAD3C ATAD3A DOCK7 MACF1 EIF3B EIF4G3 PC MAP3K7 | 3.22e-06 | 1139 | 185 | 20 | 36417873 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 DIP2B DOCK11 SPTBN1 RALGPS2 N4BP3 WNK1 WDR26 MADD KIAA0753 PIK3R4 ALMS1 SYNJ2 DOCK7 MACF1 EIF4G3 PC | 4.00e-06 | 861 | 185 | 17 | 36931259 |
| Pubmed | Temporomandibular joint formation requires two distinct hedgehog-dependent steps. | 4.32e-06 | 21 | 185 | 4 | 19815519 | |
| Pubmed | 8.13e-06 | 8 | 185 | 3 | 30914652 | ||
| Pubmed | Atad3 function is essential for early post-implantation development in the mouse. | 8.13e-06 | 8 | 185 | 3 | 23372768 | |
| Pubmed | MON2 DCAF6 ZNF219 ZNF460 YTHDC2 RALGAPA2 WDR26 GGCX ZNF512B INTS6 ATAD3B METTL13 SOWAHA ALMS1 ZFP91 INTS11 MACF1 TBX2 WDR48 | 8.89e-06 | 1116 | 185 | 19 | 31753913 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | YTHDC2 JADE1 GPBP1L1 ALMS1 CLPB MEIOC NUP37 MAP4K5 NFX1 MAP3K7 | 9.75e-06 | 322 | 185 | 10 | 39098523 |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | ASRGL1 CHERP MYO1E YTHDC2 CPT2 STT3B PIK3R4 INTS11 DOCK7 POLR1B ENDOG | 1.09e-05 | 400 | 185 | 11 | 35013556 |
| Pubmed | Identification of 15 loci influencing height in a Korean population. | 1.24e-05 | 27 | 185 | 4 | 19893584 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 1.42e-05 | 203 | 185 | 8 | 16916647 | |
| Pubmed | SEC16B ATP8B4 RALGAPA2 WNK1 GALNT16 KIAA0753 ATAD3B METTL13 ATAD3C ALMS1 ATAD3A MACF1 | 1.47e-05 | 493 | 185 | 12 | 15368895 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DIP2B NDUFAF5 YTHDC2 ARMCX4 CPT2 KBTBD7 STT3B ZNF512B ATAD3B ALMS1 TMEM242 CLPB ATAD3A NUP37 NFX1 TMEM209 MFN2 MRTO4 PRKCQ HSD17B4 MAP3K7 ENDOG | 1.67e-05 | 1496 | 185 | 22 | 32877691 |
| Pubmed | ZNF787 RGS19 WDR55 YTHDC2 N4BP3 GGCX STT3B HIRA INTS6 GPBP1L1 CLPB NUP37 ZFP91 INTS11 NFX1 MACF1 POLR1B CDYL EIF3B EIF4G3 IPMK TBX2 | 1.69e-05 | 1497 | 185 | 22 | 31527615 | |
| Pubmed | 2.06e-05 | 104 | 185 | 6 | 9205841 | ||
| Pubmed | 2.37e-05 | 11 | 185 | 3 | 36000457 | ||
| Pubmed | Hif-1alpha regulates differentiation of limb bud mesenchyme and joint development. | 2.37e-05 | 11 | 185 | 3 | 17470636 | |
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 2.37e-05 | 11 | 185 | 3 | 8954725 | |
| Pubmed | 2.37e-05 | 11 | 185 | 3 | 16678811 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 30890704 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 27817196 | ||
| Pubmed | "ATAD3C regulates ATAD3A assembly and function in the mitochondrial membrane". | 2.81e-05 | 2 | 185 | 2 | 38092275 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 22621930 | ||
| Pubmed | Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase. | 2.81e-05 | 2 | 185 | 2 | 25243911 | |
| Pubmed | Apoptotic endonuclease EndoG induces alternative splicing of Caspase-2. | 2.81e-05 | 2 | 185 | 2 | 39239896 | |
| Pubmed | Molecular characterization of the tumor-associated antigen AAA-TOB3. | 2.81e-05 | 2 | 185 | 2 | 16909202 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 11585348 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 7892212 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 19095868 | ||
| Pubmed | Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism. | 2.81e-05 | 2 | 185 | 2 | 10938127 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 29099971 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 18639545 | ||
| Pubmed | Generation of mice harboring a Sox5 conditional null allele. | 2.81e-05 | 2 | 185 | 2 | 18543318 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 21271665 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 25729399 | ||
| Pubmed | Myo1f has an essential role in γδT intraepithelial lymphocyte adhesion and migration. | 2.81e-05 | 2 | 185 | 2 | 37207213 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 6548474 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 17210950 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 26310847 | ||
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | 2.96e-05 | 164 | 185 | 7 | 22967998 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYO1E DOCK11 YTHDC2 STT3B HIRA ATAD3B SYNJ2 ZFP91 NFX1 DOCK7 MACF1 POLR1B EIF4G3 WDR48 | 3.67e-05 | 724 | 185 | 14 | 36232890 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 4.62e-05 | 120 | 185 | 6 | 31413325 | |
| Pubmed | 6.43e-05 | 15 | 185 | 3 | 20206616 | ||
| Pubmed | 7.16e-05 | 255 | 185 | 8 | 15324660 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZNF787 DIP2B CHERP PUF60 SPTBN1 TMEM43 STT3B HIRA ZNF512B INTS6 ATAD3A INTS11 DOCK7 MACF1 EIF3B HSD17B4 MED17 | 7.26e-05 | 1082 | 185 | 17 | 38697112 |
| Pubmed | 7.52e-05 | 190 | 185 | 7 | 24816252 | ||
| Pubmed | SoxD genes are required for adult neural stem cell activation. | 8.41e-05 | 3 | 185 | 2 | 35108528 | |
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 9196325 | ||
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 27515175 | ||
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 15613548 | ||
| Pubmed | Genomic structure of and a cardiac promoter for the mouse carnitine palmitoyltransferase II gene. | 8.41e-05 | 3 | 185 | 2 | 8307575 | |
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 31151054 | ||
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 17562712 | ||
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 22664726 | ||
| Pubmed | Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis. | 8.41e-05 | 3 | 185 | 2 | 30043752 | |
| Pubmed | Genetic contribution to radiographic severity in osteoarthritis of the knee. | 8.41e-05 | 3 | 185 | 2 | 22615457 | |
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 19520869 | ||
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 21302086 | ||
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 11023836 | ||
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 26150426 | ||
| Pubmed | CHD1 acts via the Hmgpi pathway to regulate mouse early embryogenesis. | 8.41e-05 | 3 | 185 | 2 | 26092847 | |
| Pubmed | Generation of mice harboring a Sox6 conditional null allele. | 8.41e-05 | 3 | 185 | 2 | 16652367 | |
| Pubmed | The kinase GLK controls autoimmunity and NF-κB signaling by activating the kinase PKC-θ in T cells. | 8.41e-05 | 3 | 185 | 2 | 21983831 | |
| Pubmed | The contribution of the citrate pathway to oxidative stress in Down syndrome. | 8.41e-05 | 3 | 185 | 2 | 27502741 | |
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 15529345 | ||
| Pubmed | SOX trio decrease in the articular cartilage with the advancement of osteoarthritis. | 8.41e-05 | 3 | 185 | 2 | 21728837 | |
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 20691246 | ||
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 35305312 | ||
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 12000749 | ||
| Pubmed | WNK1 promotes renal tumor progression by activating TRPC6-NFAT pathway. | 8.41e-05 | 3 | 185 | 2 | 31022353 | |
| Pubmed | SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells. | 8.41e-05 | 3 | 185 | 2 | 28687615 | |
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 33461373 | ||
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 21401405 | ||
| Pubmed | 8.41e-05 | 3 | 185 | 2 | 29033321 | ||
| Pubmed | Loss of Tbx4 blocks hindlimb development and affects vascularization and fusion of the allantois. | 1.14e-04 | 18 | 185 | 3 | 12736212 | |
| Pubmed | 1.14e-04 | 18 | 185 | 3 | 20056724 | ||
| Pubmed | 1.14e-04 | 18 | 185 | 3 | 12571105 | ||
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 1.17e-04 | 89 | 185 | 5 | 27034005 | |
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 1.22e-04 | 143 | 185 | 6 | 30397336 | |
| Pubmed | 1.42e-04 | 147 | 185 | 6 | 16959763 | ||
| Cytoband | 1q25.2 | 2.66e-04 | 31 | 185 | 3 | 1q25.2 | |
| Cytoband | 1p36.33 | 2.75e-04 | 77 | 185 | 4 | 1p36.33 | |
| Cytoband | 6q25.3 | 3.21e-04 | 33 | 185 | 3 | 6q25.3 | |
| GeneFamily | WD repeat domain containing | 3.43e-05 | 262 | 111 | 9 | 362 | |
| GeneFamily | UDP glucuronosyltransferases | 4.24e-05 | 32 | 111 | 4 | 363 | |
| GeneFamily | T-boxes | 1.72e-04 | 18 | 111 | 3 | 766 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.81e-04 | 206 | 111 | 7 | 682 | |
| GeneFamily | AAA ATPases | 3.13e-04 | 53 | 111 | 4 | 413 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 3.69e-04 | 5 | 111 | 2 | 655 | |
| GeneFamily | Myosins, class I | 1.02e-03 | 8 | 111 | 2 | 1097 | |
| GeneFamily | Integrator complex | 3.72e-03 | 15 | 111 | 2 | 1366 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF787 ZNF219 ZNF234 ZNF460 ZNF208 ZXDB ZNF92 ZNF335 ZFP91 ZNF727 ZNF445 | 4.63e-03 | 718 | 111 | 11 | 28 |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.18e-03 | 57 | 111 | 3 | 1179 | |
| GeneFamily | SRY-boxes | 5.97e-03 | 19 | 111 | 2 | 757 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-08 | 165 | 185 | 9 | 082f62f759a0b16ab56fad6dd4c4dd70b4f18a5c | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 1.46e-07 | 197 | 185 | 9 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-07 | 166 | 185 | 8 | 8ab18c9d911eb3a9970bba7a769294b0927538f7 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-07 | 166 | 185 | 8 | 0868f45d8d39ad39b5cee5e81ac3dd4dc512775d | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-07 | 168 | 185 | 8 | dd48da83c32d41a62f80cd7e5e5c64e42776fa27 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.61e-07 | 179 | 185 | 8 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | droplet-Kidney|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-07 | 180 | 185 | 8 | 7e5f497699876ac8e1ce780626c6f5a1f6f5f079 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.24e-06 | 188 | 185 | 8 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-06 | 196 | 185 | 8 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 1.90e-06 | 199 | 185 | 8 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.12e-06 | 156 | 185 | 7 | d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Klk6_(Klk6)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.96e-06 | 62 | 185 | 5 | 63bf0f86941cbfcac4747cc56fb9a45c8bfc9957 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Klk6_(Klk6)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.96e-06 | 62 | 185 | 5 | 0d33612f6f50f4560ff688d1a0ffb7ce444817a9 | |
| ToppCell | facs-Kidney|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-06 | 168 | 185 | 7 | d2f17a470e04f8f0edb111894027bcfc6ee1a12f | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.43e-06 | 177 | 185 | 7 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.78e-06 | 178 | 185 | 7 | 9d575902d3dbe33437c9d4200df093a741269803 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.78e-06 | 178 | 185 | 7 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 182 | 185 | 7 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 183 | 185 | 7 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-05 | 184 | 185 | 7 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 184 | 185 | 7 | c4c1a3d279ca733b865ce46570d7642dc137f9a4 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.26e-05 | 185 | 185 | 7 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-05 | 185 | 185 | 7 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-05 | 186 | 185 | 7 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-05 | 186 | 185 | 7 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-05 | 186 | 185 | 7 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 187 | 185 | 7 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 187 | 185 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 1.35e-05 | 187 | 185 | 7 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 189 | 185 | 7 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 190 | 185 | 7 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.49e-05 | 190 | 185 | 7 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.55e-05 | 191 | 185 | 7 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.60e-05 | 192 | 185 | 7 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.71e-05 | 194 | 185 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.77e-05 | 195 | 185 | 7 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.77e-05 | 195 | 185 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-05 | 198 | 185 | 7 | 8d629492d2199de8e036c19e9dacceb9c9e721a0 | |
| ToppCell | 5'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-05 | 199 | 185 | 7 | a5fffe381be1ba7d192b68d1d3937ce47663658e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-05 | 200 | 185 | 7 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-05 | 200 | 185 | 7 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.08e-05 | 200 | 185 | 7 | abcbd5a156aa4fd51d284441388975c81c0b88ae | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-05 | 200 | 185 | 7 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-05 | 200 | 185 | 7 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-05 | 200 | 185 | 7 | d9d0ffa18e5b4647966e19ad9830cbba6120677e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-05 | 200 | 185 | 7 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-05 | 200 | 185 | 7 | e9d5ba140cabae11c437012d519b85f5412dcc94 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-05 | 200 | 185 | 7 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.08e-05 | 200 | 185 | 7 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-05 | 200 | 185 | 7 | b4277b6faa69f20974696c7c422311f5c89e3663 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.03e-05 | 157 | 185 | 6 | f6210be2362d833c6d869ff921188bfc85dda11d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.03e-05 | 157 | 185 | 6 | 43a6b423fd70479822a564ff4225a1e4951ae5ed | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Lung / Manually curated celltypes from each tissue | 5.59e-05 | 160 | 185 | 6 | 9f7f24a52a24fb926df69c8e5aad64ee75a66ef1 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 162 | 185 | 6 | de0fde4310a56dc96bfc134c44d104993526d9bc | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.99e-05 | 162 | 185 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-05 | 165 | 185 | 6 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.86e-05 | 166 | 185 | 6 | 94a00edf66d54bc5f7343daea700ca26cf38fd90 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 7.09e-05 | 167 | 185 | 6 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-05 | 167 | 185 | 6 | 904a42309ef3a3695bd74c3737c6bec25b742677 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 168 | 185 | 6 | b14fd50232887b6dca1f39014d43c6f66e5c3b5c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-05 | 169 | 185 | 6 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_F|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.82e-05 | 170 | 185 | 6 | 71718dcebd48105994c313bb55babc70301170a0 | |
| ToppCell | droplet-Kidney-KIDNEY-30m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-05 | 170 | 185 | 6 | fb2771d37699c731fb569775e14a24b06ee60726 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-05 | 171 | 185 | 6 | 48fc4eca18b102b5ec5050f758281292ee8e10c6 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-05 | 171 | 185 | 6 | 05fcc72df50a380a913821b5781d9621df37d328 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.34e-05 | 172 | 185 | 6 | f6b4754a7e4b3e38030316a0ae00d932bfa87e41 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.61e-05 | 173 | 185 | 6 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.17e-05 | 175 | 185 | 6 | 13843bfc8efe7c01f19ebb6735609c1eec09c698 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.17e-05 | 175 | 185 | 6 | 955f10982a487e12cdc3a9f80b3be06bf6c59de7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-05 | 176 | 185 | 6 | 926ed37e636fe4dd3a18731cea15761f0c2c285a | |
| ToppCell | facs-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.76e-05 | 177 | 185 | 6 | d4cd54c07f1e51b5485270348fb7195d53465027 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_straight_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 180 | 185 | 6 | b34d933cdabf692f02eaaf65c2aaca1fb9510627 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 180 | 185 | 6 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 180 | 185 | 6 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | droplet-Kidney-KIDNEY|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 181 | 185 | 6 | 3a8c2bc0199b8fe2235ada14672bd31153d5a682 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 181 | 185 | 6 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 1.10e-04 | 181 | 185 | 6 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 181 | 185 | 6 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 182 | 185 | 6 | bdeebbfffc1308a29b721a5f8fed23a28d7a2f2f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 182 | 185 | 6 | f00eec1f434d92d44787d3d3343476c98c3de5b4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 182 | 185 | 6 | faf0dfa3adc2d2706b6942b5127093ccdc856447 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 182 | 185 | 6 | be8dd52898525ce6632af0adc2801944f3ac10bd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 183 | 185 | 6 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-04 | 183 | 185 | 6 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-04 | 183 | 185 | 6 | 439b1d1373b7cc73d65f3b59037a6def7cf8f4ba | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-04 | 183 | 185 | 6 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 184 | 185 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-04 | 184 | 185 | 6 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 184 | 185 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 184 | 185 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 184 | 185 | 6 | 45577ff91c3b2b303acd97239dde2463ea7a429c | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.21e-04 | 184 | 185 | 6 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.24e-04 | 185 | 185 | 6 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-04 | 185 | 185 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 185 | 185 | 6 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 187 | 185 | 6 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-04 | 187 | 185 | 6 | 689b3cc76f1e04bd35a7d3ce19e9f08744a7835b | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-04 | 187 | 185 | 6 | 4527d6426f2c4397e47f12439a13a8c14fd2aab2 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.32e-04 | 187 | 185 | 6 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-04 | 187 | 185 | 6 | b827d9da7032bf051756ddf88352af922eb0f87b | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.34e-06 | 192 | 181 | 10 | 4743_DN | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.83e-06 | 195 | 181 | 10 | 2748_DN | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; PC3; HT_HG-U133A | RALGAPA1 TPMT AKT3 ZNF219 CASP2 CPT1A GABBR2 EML3 CD101 TMEM209 | 4.59e-06 | 199 | 181 | 10 | 4668_DN |
| Drug | pregnenolone-16 alpha-carbonitrile | 1.55e-05 | 67 | 181 | 6 | CID000015032 | |
| Drug | triheptanoin | 1.69e-05 | 7 | 181 | 3 | CID000069286 | |
| Drug | entacapone | 1.69e-05 | 20 | 181 | 4 | ctd:C071192 | |
| Drug | pheophytin | HFE UGT1A10 UGT1A7 UGT3A1 LCT F8 ABCB4 ALMS1 HPR PRKCQ MCF2L | 1.81e-05 | 284 | 181 | 11 | CID000000250 |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.22e-05 | 190 | 181 | 9 | 3373_DN | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A | 2.41e-05 | 192 | 181 | 9 | 3252_DN | |
| Drug | Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.51e-05 | 193 | 181 | 9 | 5430_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.73e-05 | 195 | 181 | 9 | 5307_DN | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.73e-05 | 195 | 181 | 9 | 3330_DN | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.73e-05 | 195 | 181 | 9 | 4345_DN | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.84e-05 | 196 | 181 | 9 | 5418_DN | |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A | 2.96e-05 | 197 | 181 | 9 | 7351_UP | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.96e-05 | 197 | 181 | 9 | 5340_DN | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.96e-05 | 197 | 181 | 9 | 5309_UP | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 2.96e-05 | 197 | 181 | 9 | 5262_UP | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.96e-05 | 197 | 181 | 9 | 6026_DN | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.20e-05 | 199 | 181 | 9 | 6244_DN | |
| Drug | PF-00539758-00 [351321-34-1]; Down 200; 10uM; PC3; HT_HG-U133A | 3.20e-05 | 199 | 181 | 9 | 6379_DN | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; HL60; HT_HG-U133A | 3.20e-05 | 199 | 181 | 9 | 3133_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.20e-05 | 199 | 181 | 9 | 3566_UP | |
| Drug | methyl palmoxirate | 5.04e-05 | 26 | 181 | 4 | CID000068593 | |
| Drug | Perhexiline | 6.29e-05 | 2 | 181 | 2 | DB01074 | |
| Disease | neuromuscular disease (implicated_via_orthology) | 9.04e-07 | 4 | 181 | 3 | DOID:440 (implicated_via_orthology) | |
| Disease | angiopoietin-related protein 1 measurement | 3.92e-06 | 18 | 181 | 4 | EFO_0801382 | |
| Disease | serum metabolite measurement | SOX6 RALGAPA1 DMGDH ASRGL1 MYO1E HYKK UGT1A10 UGT1A7 UBTFL1 UGT3A1 CPT1A CPT2 FAAH ABCB4 ALMS1 MAP4K5 GADL1 DOCK7 ENDOG | 6.21e-06 | 945 | 181 | 19 | EFO_0005653 |
| Disease | docosahexaenoic acid measurement | 1.40e-05 | 127 | 181 | 7 | EFO_0007761 | |
| Disease | metabolite measurement | DMGDH ATP8B4 ASRGL1 UGT1A10 UGT1A7 UGT3A1 LIPF CPT2 FAAH ALMS1 MAP4K5 GADL1 ENDOG | 4.59e-05 | 560 | 181 | 13 | EFO_0004725 |
| Disease | gallstones | 5.59e-05 | 108 | 181 | 6 | EFO_0004210 | |
| Disease | age at menarche | SOX5 SEC16B AKT3 CPA5 TRPC6 ZNF75CP ATE1 HELQ MADD FAAH2 ALMS1 USP35 EIF4G3 | 8.31e-05 | 594 | 181 | 13 | EFO_0004703 |
| Disease | syndrome (implicated_via_orthology) | 1.73e-04 | 18 | 181 | 3 | DOID:225 (implicated_via_orthology) | |
| Disease | age-related hearing impairment | 1.87e-04 | 324 | 181 | 9 | EFO_0005782 | |
| Disease | cholelithiasis | 2.13e-04 | 88 | 181 | 5 | EFO_0004799 | |
| Disease | X-24544 measurement | 2.23e-04 | 4 | 181 | 2 | EFO_0800892 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 2.53e-04 | 50 | 181 | 4 | EFO_0022303 | |
| Disease | cholesterol to total lipids in large HDL percentage | 3.66e-04 | 55 | 181 | 4 | EFO_0022234 | |
| Disease | cotinine measurement | 3.67e-04 | 23 | 181 | 3 | EFO_0007813 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 3.70e-04 | 5 | 181 | 2 | EFO_0801060 | |
| Disease | chronic fatigue syndrome (is_implicated_in) | 3.70e-04 | 5 | 181 | 2 | DOID:8544 (is_implicated_in) | |
| Disease | 5-hydroxyindole sulfate measurement | 3.70e-04 | 5 | 181 | 2 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 3.70e-04 | 5 | 181 | 2 | EFO_0801853 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.61e-04 | 222 | 181 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | paracentral lobule volume measurement | 4.73e-04 | 25 | 181 | 3 | EFO_0010317 | |
| Disease | lipid metabolism disorder (is_implicated_in) | 5.52e-04 | 6 | 181 | 2 | DOID:3146 (is_implicated_in) | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 6.15e-04 | 63 | 181 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 6.15e-04 | 63 | 181 | 4 | EFO_0022239 | |
| Disease | ceramide measurement | 6.46e-04 | 235 | 181 | 7 | EFO_0010222 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 6.53e-04 | 64 | 181 | 4 | EFO_0022253 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 7.14e-04 | 239 | 181 | 7 | EFO_0008317, EFO_0020945 | |
| Disease | neuropilin-1 measurement | 7.70e-04 | 7 | 181 | 2 | EFO_0020603 | |
| Disease | X-21339 measurement | 7.70e-04 | 7 | 181 | 2 | EFO_0800808 | |
| Disease | total lipids in small VLDL | 7.77e-04 | 67 | 181 | 4 | EFO_0022148 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 8.16e-04 | 30 | 181 | 3 | C1868672 | |
| Disease | level of Phosphatidylcholine (18:0_20:4) in blood serum | 8.99e-04 | 31 | 181 | 3 | OBA_2045094 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0800909 | |
| Disease | intertrochanteric region size | 1.02e-03 | 8 | 181 | 2 | EFO_0010075 | |
| Disease | serum N-desmethylclozapine measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0800766 | |
| Disease | internet addiction disorder | 1.08e-03 | 33 | 181 | 3 | EFO_0803368 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.13e-03 | 74 | 181 | 4 | EFO_0022280 | |
| Disease | forced expiratory volume | DMGDH GDF5 ATP8B4 HYKK DOCK9 RALGPS2 ATE1 ANGPTL1 EML3 KIAA0753 EYS ERCC6L2 PC | 1.23e-03 | 789 | 181 | 13 | EFO_0004314 |
| Disease | C-reactive protein measurement | SOX6 SOX5 DMGDH SEC16B AKT3 UBE4B HYKK NUP210L YTHDC2 EML3 MADD MAP4K5 HPR DOCK7 MACF1 POLR1B EIF4G3 | 1.27e-03 | 1206 | 181 | 17 | EFO_0004458 |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.27e-03 | 264 | 181 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | X-11442 measurement | 1.31e-03 | 9 | 181 | 2 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.31e-03 | 9 | 181 | 2 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.31e-03 | 9 | 181 | 2 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.31e-03 | 9 | 181 | 2 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.31e-03 | 9 | 181 | 2 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.31e-03 | 9 | 181 | 2 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.31e-03 | 9 | 181 | 2 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.31e-03 | 9 | 181 | 2 | EFO_0802127 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 5 measurement | 1.31e-03 | 9 | 181 | 2 | EFO_0801766 | |
| Disease | Disorder of fatty acid metabolism | 1.31e-03 | 9 | 181 | 2 | cv:C0268634 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.31e-03 | 9 | 181 | 2 | EFO_0004570, GO_0009410 | |
| Disease | serum gamma-glutamyl transferase measurement | DMGDH UBR1 SEC16B DOCK11 NUP210L UGT1A10 UGT1A7 EYS SOWAHA GPBP1L1 SYNJ2 MAP4K5 HPR ZFP91 | 1.59e-03 | 914 | 181 | 14 | EFO_0004532 |
| Disease | Optic Atrophy | 1.63e-03 | 10 | 181 | 2 | C0029124 | |
| Disease | Inherited focal segmental glomerulosclerosis | 1.63e-03 | 10 | 181 | 2 | cv:CN327126 | |
| Disease | bilirubin measurement, response to tenofovir | 1.63e-03 | 10 | 181 | 2 | EFO_0004570, EFO_0009279 | |
| Disease | indoleacetate measurement | 1.63e-03 | 10 | 181 | 2 | EFO_0021015 | |
| Disease | X-21448 measurement | 1.63e-03 | 10 | 181 | 2 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.63e-03 | 10 | 181 | 2 | EFO_0802185 | |
| Disease | Focal segmental glomerulosclerosis | 1.63e-03 | 10 | 181 | 2 | cv:C0017668 | |
| Disease | X-23974 measurement | 1.63e-03 | 10 | 181 | 2 | EFO_0800867 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.64e-03 | 276 | 181 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | ciliopathy (implicated_via_orthology) | 1.90e-03 | 40 | 181 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | phosphatidylcholine measurement | 1.93e-03 | 284 | 181 | 7 | EFO_0010226 | |
| Disease | pregnenetriol sulfate measurement | 1.98e-03 | 11 | 181 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.98e-03 | 11 | 181 | 2 | EFO_0600039 | |
| Disease | lignoceroylcarnitine (C24) measurement | 1.98e-03 | 11 | 181 | 2 | EFO_0800541 | |
| Disease | histidine betaine (hercynine) measurement | 1.98e-03 | 11 | 181 | 2 | EFO_0800972 | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 1.98e-03 | 11 | 181 | 2 | cv:CN043612 | |
| Disease | X-21796 measurement | 1.98e-03 | 11 | 181 | 2 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 1.98e-03 | 11 | 181 | 2 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 1.98e-03 | 11 | 181 | 2 | EFO_0010219 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.99e-03 | 144 | 181 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | emphysema imaging measurement | 2.11e-03 | 146 | 181 | 5 | EFO_0007626 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.18e-03 | 147 | 181 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | volumetric bone mineral density | 2.19e-03 | 42 | 181 | 3 | EFO_0007620 | |
| Disease | brain measurement, neuroimaging measurement | SOX5 GDF5 DIP2B AKT3 SPTBN1 RALGPS2 NPIPB8 MACF1 PAPPA MAP3K7 | 2.21e-03 | 550 | 181 | 10 | EFO_0004346, EFO_0004464 |
| Disease | triglycerides in large LDL measurement | 2.34e-03 | 43 | 181 | 3 | EFO_0022319 | |
| Disease | p-cresol glucuronide measurement | 2.37e-03 | 12 | 181 | 2 | EFO_0800079 | |
| Disease | biliverdin measurement | 2.37e-03 | 12 | 181 | 2 | EFO_0021033 | |
| Disease | tumor protein p53-inducible protein 11 measurement | 2.37e-03 | 12 | 181 | 2 | EFO_0802169 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.37e-03 | 150 | 181 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | platelet component distribution width | AKT3 NUP210L DOCK9 DOCK10 PRELID3B WNK1 METTL13 CLPB MEIOC SYNJ2 DOCK7 MACF1 | 2.53e-03 | 755 | 181 | 12 | EFO_0007984 |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.67e-03 | 224 | 181 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.73e-03 | 225 | 181 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 2.79e-03 | 13 | 181 | 2 | cv:C4273714 | |
| Disease | pregnenetriol disulfate measurement | 2.79e-03 | 13 | 181 | 2 | EFO_0800587 | |
| Disease | apolipoprotein E measurement | 2.79e-03 | 13 | 181 | 2 | EFO_0008029 | |
| Disease | retinol dehydrogenase 16 measurement | 2.79e-03 | 13 | 181 | 2 | EFO_0802007 | |
| Disease | phospholipids:total lipids ratio | 2.86e-03 | 227 | 181 | 6 | EFO_0020946 | |
| Disease | lysophosphatidylcholine 16:1 measurement | 3.24e-03 | 14 | 181 | 2 | EFO_0010358 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 3.60e-03 | 50 | 181 | 3 | C1449563 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WNSMAVKGRALKCFH | 886 | Q8NDM7 | |
| ADETFWKHFLTLKMN | 191 | O00421 | |
| WSHDGKFFARMTLDT | 431 | P55884 | |
| TSMPWAAAKDGKLHF | 281 | Q7L266 | |
| GNHSSRWLYEAMAKA | 336 | P17405 | |
| GVTAMHKLFDWANTS | 436 | Q9NVI7 | |
| FSWHREDMQESLGRK | 321 | Q96PJ5 | |
| EESRVRAHAWNMKFN | 2506 | Q8TCU4 | |
| LGKSVFMRHSWKDFF | 3501 | Q8TCU4 | |
| VFKNGKMGLNAEHSW | 461 | P50416 | |
| GLMEKFADSSHSWNV | 1711 | Q86UQ4 | |
| MWHNGKQFTTLDRDK | 411 | O95841 | |
| FMGILSWKDSKHSLN | 211 | Q8TF62 | |
| HRNSRTMIKEANFWG | 716 | Q58WW2 | |
| RDSCAAGTKHWTMNL | 351 | Q13319 | |
| AKMHAISGNHFWTAK | 591 | Q9NRI5 | |
| DGAMIWSETKFAHQS | 1991 | Q5H9R4 | |
| AKEIMRHSFFSGVNW | 396 | Q9Y243 | |
| NMLHGDGTNRWFDKS | 341 | P23786 | |
| KSWFNHLGKYDAQMD | 301 | Q8N428 | |
| MFGWGDFHSNIKTVK | 111 | O95156 | |
| LSMSQLKQWKHFSGD | 866 | Q9Y620 | |
| DIAWMKFDAQGHLRA | 311 | P35558 | |
| AIKAGWKENHATFMN | 61 | Q9UL03 | |
| MVQGWHRKATSCGFL | 1401 | O75140 | |
| QDVNITGHFSWKMAK | 561 | P23352 | |
| LQDSVLAFWKHGMQG | 826 | Q8IVH8 | |
| LAFWKHGMQGRSFRS | 831 | Q8IVH8 | |
| WDSTFDAHINKGRVM | 56 | Q04759 | |
| SRKALHVNFKDMGWD | 401 | P43026 | |
| WSSGSRHMKKQTFVV | 1431 | Q8WXG6 | |
| AKATAHNSSWGEMQA | 16 | Q9HCI5 | |
| FGCRLKGMHTVNSKW | 126 | Q5T1H1 | |
| RQNGAQKSWDFMKTH | 26 | O95848 | |
| GMLHAGQSLQIFRKW | 326 | Q5TA45 | |
| AWKANRMEHKSGSLS | 251 | Q9HC44 | |
| AKGSFPWQAKMVSHH | 111 | P00739 | |
| AWAQNHRTMSLAKRV | 131 | P25089 | |
| DGFAFTHSMNRLWRK | 241 | Q8WXQ8 | |
| MFHWTQAVKSGKFQA | 291 | P07098 | |
| KMLSAFNATSGKAIW | 231 | A2RU67 | |
| DIQTHMTNNKGSAAW | 181 | O43318 | |
| KTIFWSRNGHDGSMD | 106 | E9PQR5 | |
| FKKDAGLWHGMFANV | 561 | Q9P265 | |
| TFLTQKWCMGKHEFR | 796 | Q12986 | |
| GDSWQGKRHLFIMCS | 171 | Q96LW2 | |
| DTMKWKVGNRSELQH | 1166 | P09848 | |
| VFQLLHWNGSLKAMR | 236 | Q8IVB5 | |
| KLSLGTFQAWHGMQF | 641 | Q96QE4 | |
| AASARAWPKMHTVNG | 241 | P00451 | |
| AKVMGWQVLSFSNHV | 541 | Q9NVC6 | |
| HNMWLNCASLKRSDF | 501 | Q8WVZ9 | |
| QLSQSLKGWDHMFTV | 86 | Q30201 | |
| VARQHASSGKFDSMW | 1476 | Q7Z3U7 | |
| LMSAHWCLKNTFKVG | 211 | Q8NFH4 | |
| DNVKHAWSPMKDGSS | 291 | Q13219 | |
| LGMNSWDRRKNFHLL | 1611 | Q2PPJ7 | |
| NMKFRSSWVFIAAKG | 181 | P58499 | |
| WKSMSQEHLNGNVLS | 346 | Q8NFU5 | |
| SCWSDGKMFNALIHR | 221 | Q9UPN3 | |
| NKAGWLDSELNMFTH | 736 | O95140 | |
| LRQDMSWFDDHKNST | 796 | P21439 | |
| QGHFMFILKKSSSLW | 701 | Q5VYJ5 | |
| KQLQGHMWRAAFTAG | 111 | Q9UHY7 | |
| WKHGNKSLNTEEHMS | 216 | A8MPY1 | |
| DFAHSSFQMALSKGW | 191 | O75874 | |
| HGNTRLEKMDWATFQ | 481 | Q93033 | |
| VTAKTGWKHLQQMFD | 336 | A2RU49 | |
| NFNHVSLKASWVMGR | 741 | Q9BX69 | |
| TWLESMAKIHARNGD | 1701 | Q96BY6 | |
| WLDSMAKIHVKNGDF | 1621 | Q5JSL3 | |
| FGSQENLRWRKDMTH | 1436 | Q96N67 | |
| TWLDSMARIHVKNGD | 1616 | Q9BZ29 | |
| LDMQGKQSRASFAWH | 126 | Q96LM5 | |
| KQSRASFAWHMSAFE | 131 | Q96LM5 | |
| DAISAGKNWMFSNAK | 171 | Q8IWX8 | |
| MTFQASHRSAWGKSR | 1 | Q9Y232 | |
| AAKMRFHSQLFSQDW | 346 | O60609 | |
| TWYHAANSKKAMTAA | 71 | Q8WW52 | |
| GSFQVTRAAWEHMKK | 126 | P51659 | |
| REGVTAMHKLFDWAN | 211 | Q5T2N8 | |
| AMHKLFDWANTSRRG | 216 | Q5T2N8 | |
| VNDLFDRDWHKMALS | 356 | Q8NFW1 | |
| NSRAKSNGMWFKLHD | 156 | Q92496 | |
| SFQLWIAMMSAKGHD | 356 | Q6GMR7 | |
| QRLESKCSMGFHAGW | 476 | Q9UI17 | |
| LMQGSFSVWTDHKRG | 831 | O15068 | |
| CKNESGSRSNGMWAH | 26 | O95260 | |
| TAFGAMFAKTWRVHA | 566 | O75899 | |
| HVNRTGWTMAQNKLF | 126 | Q9P2N6 | |
| NAKHRLGWTALMVAA | 161 | Q9H078 | |
| HLDWSKDGNFIMSNS | 731 | Q32P44 | |
| AFLSNMKSRSAGKLW | 431 | O00519 | |
| DASWGGSALMSRKHR | 301 | Q6ZQY3 | |
| NHMSRWAAHDVFELK | 1146 | Q5T890 | |
| NDLGDHSMKERDWKS | 211 | Q8TDG4 | |
| EGWKTNMDFVGHRKA | 256 | P54198 | |
| WFGFSQSDRMKVHIA | 536 | Q8N6R0 | |
| QMSHKKVGALWREAD | 1366 | O43432 | |
| KTIFWSRNGHDGSMD | 106 | E9PJ23 | |
| AGSWSTFQHKELMAA | 6 | P42575 | |
| LAWAGLNGTHSDMLK | 1211 | Q56UN5 | |
| SVLAFWKHGMQGKSF | 781 | Q9Y4K4 | |
| IRNAWKHSRMFFGKN | 56 | Q9UKD2 | |
| SNANPGLTFHWSMSK | 1206 | Q5VU65 | |
| AGNRMNAMLWFKHLS | 551 | Q86X27 | |
| TVKSSGWSRKFHNFM | 276 | Q7Z2Y5 | |
| GWSRKFHNFMEKCTI | 281 | Q7Z2Y5 | |
| FHMNWSEEKSRGQVK | 71 | Q9BQQ7 | |
| LKSVWPMNTSRFADH | 161 | A2RUB1 | |
| SWAQSFDKLMHSPAG | 86 | P49795 | |
| VFHRELRSNSMKTWG | 296 | Q9BTV4 | |
| SNASKGREAMEWVIH | 151 | Q9Y3B1 | |
| VFMWLKHEATRGNAA | 676 | Q68CR1 | |
| MASERGKVKHNWSST | 1 | Q93075 | |
| SWDSVTMKHKGFAFV | 161 | Q9UHX1 | |
| SFKAMWSLNGHSLSK | 426 | O15056 | |
| TLMATTFRRKGGNHW | 256 | Q9H7F4 | |
| KKMFGWGDFHSNIKT | 116 | P58417 | |
| HMTTAGKTNQKLEWA | 91 | P35243 | |
| HLAAAANHRWSQKAM | 141 | Q14249 | |
| GWSGFISHQMLKRRS | 566 | Q16819 | |
| VMRGNCSFHTKGWLA | 96 | Q8IUH8 | |
| DLKWHSAFFRKQMGT | 571 | Q6IE81 | |
| KSWAMSKLAAAHRGA | 296 | Q2KHM9 | |
| MGESNCAWNRKALLH | 261 | Q5TEU4 | |
| QRSLMDWSFTEHFKP | 776 | Q6Q759 | |
| SKWLKHQAFMAELAS | 1311 | Q01082 | |
| PSAQMEGFLNRKHEW | 2196 | Q01082 | |
| MHNSNISKILGSRWK | 646 | P35712 | |
| REGVTAMHKLFDWAN | 386 | Q5T9A4 | |
| AMHKLFDWANTSRRG | 391 | Q5T9A4 | |
| WNGDLAKMTHLQAGL | 16 | Q8IUQ0 | |
| MITFLNDKNDWHLRG | 581 | Q99570 | |
| HSWSVNNFLMTGPKA | 21 | Q93098 | |
| ECGKAFMWISALSQH | 316 | A8MUV8 | |
| CGWNFTSMSKLLRHK | 461 | P98169 | |
| LTDHMDFWGRVKNFL | 191 | Q6NUS8 | |
| WSSAFTKHKRNHMED | 436 | Q03936 | |
| GKAFTRMSGLTRHQW | 426 | Q14592 | |
| SHMDWGKVAFKNFSG | 46 | P0CB48 | |
| FTQSRRWKDHADMLK | 431 | P38435 | |
| GFSDAMTFKERVWNH | 196 | Q9HAW8 | |
| VWNAHKGFCMSTLRT | 101 | Q8TAF3 | |
| STQSHMDWGKVAFKN | 36 | P0CB47 | |
| KFHQDSWSSKEMQHL | 231 | P0CB47 | |
| HSAWAMGMRVNFLAS | 251 | O95497 | |
| NDFWGKGMAENTSHK | 76 | Q8IUR5 | |
| ILGMNSWDKRRSFHL | 1771 | Q6GYQ0 | |
| RDFMSGFTALHWAAK | 341 | Q2M3V2 | |
| KFHNSRWMVAGKADP | 166 | Q13207 | |
| FAHSLRKFSMRDWGI | 331 | Q9P2C4 | |
| ARKWSNSQPADLAHM | 141 | Q9BRG2 | |
| WNNSHIALVGKAMSS | 626 | Q8TCJ2 | |
| FMRKGTVGDWKNHFT | 256 | O00338 | |
| KSLWQNIAHHGTFME | 1001 | O95155 | |
| MTKLQWLFGFLEHSQ | 481 | Q9P2H5 | |
| DRRFRWSSGLNKHFM | 326 | Q92670 | |
| EIMAHQKFALRLGSW | 306 | Q8IWV7 | |
| FASSIGSHNMTLRWK | 106 | P08922 | |
| GSHNMTLRWKSANFS | 111 | P08922 | |
| NFGAHWMKAPVSFSK | 131 | O15178 | |
| WIEKANHSMAVKGRS | 186 | Q5JUR7 | |
| SKTNMHARNLALVWA | 161 | Q2M1Z3 | |
| AMKNHLWGHALFLSS | 461 | Q96JE7 | |
| MAARVGAFLKNAWDK | 1 | O95167 | |
| RQLLDHMDSWTAKFR | 326 | Q96SK2 | |
| GFKWSLNLDMHQRVH | 576 | Q14588 | |
| LMNDWKDEFKAHSRV | 91 | Q96KM6 | |
| ANVHSKASNGWMALD | 531 | Q9H6S0 | |
| DHMALLRAFQAWQKA | 896 | Q9H6S0 | |
| CGKTFRWSSNLARHM | 1011 | P59923 | |
| GKAFNWSSNLMEHKK | 431 | O43345 | |
| AFNWSSNLMEHKRIH | 701 | O43345 | |
| GKAFNWSSNLMEHKR | 1091 | O43345 | |
| ASSGHDQRLKFWDMA | 311 | Q9H6Y2 | |
| ASMSSLNKWIFTVHG | 61 | Q6ICL7 | |
| MHNSNISKILGSRWK | 581 | P35711 | |
| GFTCRQKASLNWHMK | 406 | Q96JP5 | |
| ATGAHWMRQLVSFQK | 156 | P57082 | |
| MAFWHASKAQSIIDA | 546 | Q9Y210 | |
| TKFRNHVMEGDWDKA | 161 | Q9H7D7 | |
| HKLVDNWARDAMNLS | 2251 | Q9H4A3 | |
| LTDHMDFWGRVKNFL | 191 | Q3SY77 | |
| AMIVNKASWERGFAH | 756 | Q9H9Y6 | |
| VWKALGVHSMNDFRS | 101 | Q9NWH2 | |
| GKAVEMKWFADRGHS | 71 | P51580 | |
| RWSSLKEHMFNHVGS | 506 | Q9H4Z2 | |
| HNFSKLFSMENWGGA | 596 | P11498 | |
| QSFTQSWFLKGHMRK | 281 | Q9P2Y4 | |
| GFSDAMTFKERVWNH | 196 | Q9HAW7 | |
| DTHKAFAKAFWRMDR | 281 | A8MPX8 | |
| ECGKRFSWSSNLMQH | 126 | Q6DD87 | |
| RQMDSKWGGKSESIH | 326 | Q12965 | |
| MGSKERFHWQSHNVK | 1 | O00160 | |
| MQSLASHKGQKLWRS | 131 | O15049 | |
| MVWRFQKHIGKGSSQ | 1 | Q8NBZ9 | |
| NALNMSDAHYKADWK | 1531 | P20929 |